E Bobbio-Pallavicini

Author

Istituti di Ricovero e Cura a Carattere Scientifico

Also Known As

E Bobbio-Pallavicini, E. BOBBIO‐PALLAVICINI, E. Bobbio-Pallavicini, E. Bobbio‐Pallavicini, E.N.rico Bobbio-Pallavicini, Enrico Bobbio-Pallavicini, Enrico Bobbio‐Pallavicini, Gengo Osawa

Publications

636

Citations

H-Index

Concepts

All Affiliations

Istituti di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo Fondazione University of Pavia Azienda Ospedaliera Ospedale Maggiore Ospedale Maggiore

About

E Bobbio-Pallavicini is an author at Istituti di Ricovero e Cura a Carattere Scientifico specializing in medicine, hematology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	296
2	Immunology	3	3	120
3	Allergy	2	2	93
4	Health Sciences	1	1	14
5	Hepatology	1	1	58

E Bobbio-Pallavicini

Publications

526

Citations

H-Index

Page 1

	Year	Citations
Antiplatelet agents in thrombotic thrombocytopenic purpura (TTP). Results of a randomized multicenter trial by the Italian Cooperative Group for TTP. E Bobbio-Pallavicini, L Gugliotta, Riccardo Centurioni, PubMed	1997	113
Vincristine sulfate for the treatment of thrombotic thrombocytopenic purpura refractory to plasma‐exchange E Bobbio-Pallavicini, Camillo Porta, Riccardo Centurioni, European Journal Of Haematology ThrombosisItalian Cooperative GroupBlood PlateletPharmacologyHematology	1994	63
Epirubicin and etoposide combination chemotherapy to treat hepatocellular carcinoma patients: a phase II study E Bobbio-Pallavicini, Camillo Porta, Mauro Moroni, European Journal of Cancer OncologyHepatologyHepatocellular Carcinoma PatientsMedicineEtoposide Combination Chemotherapy	1997	58
Sarcoidosis following beta-interferon therapy for multiple myeloma. E Bobbio-Pallavicini, Carla Valsecchi, F Tacconi, PubMed Hematological MalignancyAllergyPulmonary PathologySclerodermaAutoimmune Disease	1995	54
Thrombotic thrombocytopenic purpura treatment in year 2000. Camillo Porta, E Bobbio-Pallavicini PubMed	2000	46
Sarcoidosis following beta-interferon therapy for multiple myeloma E Bobbio-Pallavicini, Chiara Valsecchi, F Tacconi, Pneumologie Hematological MalignancyAllergyAutoimmune DiseaseSclerodermaPulmonary Pathology	1995	39
Treatment of thrombotic thrombocytopenic purpura with high-dose immunoglobulins. Results in 17 patients. Italian Cooperative Group for TTP. Riccardo Centurioni, E Bobbio-Pallavicini, Camillo Porta, PubMed	1995	35
Anti-phospholipid antibodies and thrombotic thrombocytopenic purpura. Carlomaurizio Montecucco, Manuela Di Lauro, E Bobbio-Pallavicini, PubMed ThrombopoiesisThrombosisAutoimmune DiseaseBlood PlateletLupus	1988	27
Cancer Chemotherapy-Related Thrombotic Thrombocytopenic Purpura: Biological Evidence of Increased Nitric Oxide Production Camillo Porta, Marco Danova, Alberto Riccardi, Mayo Clinic Proceedings ThrombopoiesisNitric Oxide ProductionBiological EvidenceMedicineHematology	1999	23
Folinic Acid Does Improve 5-Fluorouracil Activity<i>In Vivo.</i>Results of a Phase III Study Comparing 5-Fluorouracil to 5-Fluorouracil and Folinic Acid in Advanced Colon Cancer Patients E Bobbio-Pallavicini, Camillo Porta, Mauro Moroni, Journal of Chemotherapy	1993	22

Page 1